Portage Biotech
PRTG
#10352
Rank
โ‚ฌ13.46 M
Marketcap
Country
5,91ย โ‚ฌ
Share price
-2.16%
Change (1 day)
45.03%
Change (1 year)

EPS for Portage Biotech (PRTG)

EPS in 2024 (TTM): -42,09ย โ‚ฌ

According to Portage Biotech's latest financial reports the company's current EPS (TTM) is -40,13ย โ‚ฌ. an increase over its 2023 EPS that were of -112,64ย โ‚ฌ.

EPS history for Portage Biotech from 1998 to 2024

Annual EPS

Year EPS Change
2024-67,51ย โ‚ฌ-40.06%
2023-112,64ย โ‚ฌ403.1%
2022-22,39ย โ‚ฌ-4.44%
2021-23,43ย โ‚ฌ175.51%
2020-8,50ย โ‚ฌ-10.91%
2019-9,55ย โ‚ฌ-101.19%
2018802,02ย โ‚ฌ670.17%
2017104,14ย โ‚ฌ-400%
2016-34,71ย โ‚ฌ-0%
2015-34,71ย โ‚ฌ-50%
2014-69,42ย โ‚ฌ126.07%
2013-30,71ย โ‚ฌ-43.75%
2012-54,60ย โ‚ฌ-35.49%
2011-84,64ย โ‚ฌ-44.77%
2010-153,23ย โ‚ฌ457.4%
2009-27,49ย โ‚ฌ-18.48%
2008-33,72ย โ‚ฌ-358.54%
200713,04ย โ‚ฌ-102.83%
2006-461,52ย โ‚ฌ-25.19%
2005-616,94ย โ‚ฌ-335.6%
2004261,86ย โ‚ฌ16.39%
2003224,99ย โ‚ฌ-82.54%
20021.289ย โ‚ฌ-34.17%
20011.958ย โ‚ฌ-145.02%
2000-4.348ย โ‚ฌ58.94%
1999-2.736ย โ‚ฌ-35.44%
1998-4.237ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-0,05207ย โ‚ฌ-99.87% Bahamas
NRC Health
NRC
0,61ย โ‚ฌ-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA